227 related articles for article (PubMed ID: 25325277)
1. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Chun AR; Jo HM; Lee SH; Chun HW; Park JM; Kim KJ; Jung CH; Mok JO; Kang SK; Kim CH; Kim BY
Endocrinol Metab (Seoul); 2015 Mar; 30(1):71-7. PubMed ID: 25325277
[TBL] [Abstract][Full Text] [Related]
2. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
Kao YH; Lim SS; Ong SC; Padhy AK
Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
Zhai G; Zhang M; Xu H; Zhu C; Li B
J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895
[TBL] [Abstract][Full Text] [Related]
5. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
Hagenimana N; Dallaire J; Vallée É; Belzile M
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
[TBL] [Abstract][Full Text] [Related]
6. [Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
Ladrón de Guevara H D; Munizaga M C; García S N; Letelier B C; Wash F A
Rev Med Chil; 2020 Jan; 148(1):10-16. PubMed ID: 32730431
[TBL] [Abstract][Full Text] [Related]
7. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
9. Synchronous thyroid cancer on the edge: Incidentalomas of 18F-FDG PET/CT in clinical practice.
Ayan A; Basaran Y; Kirnap NG; Cinar A
Niger J Clin Pract; 2021 Jun; 24(6):937-942. PubMed ID: 34121744
[TBL] [Abstract][Full Text] [Related]
10.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
11. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
[TBL] [Abstract][Full Text] [Related]
16. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Incidentalomas on
Makis W; Ciarallo A
Mol Imaging Radionucl Ther; 2017 Oct; 26(3):93-100. PubMed ID: 28976331
[TBL] [Abstract][Full Text] [Related]
18. The Frequency of Focal Thyroid Incidental Findings and Risk of Malignancy Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography in an Iodine Deficient Population.
Gedberg N; Karmisholt J; Gade M; Fisker RV; Iyer V; Petersen LJ
Diagnostics (Basel); 2018 Jul; 8(3):. PubMed ID: 30018271
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
Bertagna F; Treglia G; Piccardo A; Giubbini R
J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
[TBL] [Abstract][Full Text] [Related]
20. Focal Thyroid Incidentalomas on
de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
